Safety and Immunogenicity of a Chlamydia Vaccine CTH522
Clinical trial NCT03926728 · COMPLETED
Trial details
- NCT number
- NCT03926728
- Sponsor
- Statens Serum Institut
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-17
- Primary completion
- 2022-02-22
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.